Log In
Print
BCIQ
Print
Print this Print this
 

Anti-miR-33

  Manage Alerts
Collapse Summary General Information
Company Regulus Therapeutics Inc.
DescriptionOligonucleotide targeting miR-33
Molecular Target MicroRNA-33 (miR-33)
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: microRNA

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today